PK-PD relationship of the effects of argatroban on haemostasis in healthy young volunteers.

被引：1
|
作者：
Garrigou, D
Dubruc, C
Thuillez, C
Bergougnan, L
Thenot, JP
机构：
[1] Synthelabo Rech, Chilly Mazarin, France
[2] CHU Rouen, Serv Pharmacol Clin, Rouen, France
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 1999年 / 65卷 / 02期
关键词：
D O I：
10.1016/S0009-9236(99)80136-2
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
PII18
引用
收藏
页码：151 / 151
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETIC-PHARMACODYNAMIC (PK-PD) MODELING FOR METFORMIN IN HEALTHY VOLUNTEERS.
    Kim, Y.
    Cho, S.
    Lee, D.
    Son, H.
    Roh, H.
    Son, M.
    Heo, Y.
    Park, K.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S48 - S48
  • [2] Effects of a 24 hours infusion of argatroban in healthy volunteers.
    Bergougnan, L
    Caplain, H
    Brohier, S
    Dubruc, C
    Cabanis, MJ
    Rosenzweig, P
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1997, 61 (02) : PII36 - PII36
  • [3] Effects of age and gender on the pharmacokinetics and pharmacodynamics of argatroban in healthy volunteers.
    Hursting, MJ
    Joffrion, JL
    Brooks, RL
    BLOOD, 1996, 88 (10) : 3055 - 3055
  • [4] Pharmacokinetic/pharmacodynamic (PK/PD) modeling of captopril in healthy volunteers.
    Yi, SY
    Bae, KS
    Lim, HS
    Cho, JY
    Yu, KS
    Jang, IJ
    Shin, SG
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (02) : P74 - P74
  • [5] Pharmacokinetics (PK) and pharmacodynamics (PD) of interferon β-1a in healthy volunteers.
    Buchwalder, PA
    Buclin, T
    Trinchard, I
    Munafo, A
    Biollaz, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 166 - 166
  • [6] PK/PD modeling of QTc duration for vardenafil & sildenafil in healthy volunteers.
    Patel, BR
    Boyle, DA
    Diringer, KA
    Ilson, BE
    Shaddinger, BC
    Montague, TH
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 75 (02) : P89 - P89
  • [7] PK-PD INTERACTION OF KETOROLAC AND FUROSEMIDE IN HEALTHY-VOLUNTEERS IN A NORMOVOLEMIC STATE
    SHAH, J
    BULLINGHAM, R
    JONKMAN, J
    CURD, J
    TAYLOR, R
    FRATIS, A
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (02) : 198 - 198
  • [8] Pharmacokinetics (PK) and pharmacodynamics (PD) of a combination of tramadol (T) and acetaminophen (A) in healthy volunteers.
    Rollason, V
    Vogt, N
    Deloche, C
    Piguet, V
    Dayer, R
    Desmeules, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2002, 71 (02) : P52 - P52
  • [9] Pharmacokinetics (PK) of intravenous scopolamine (SCP) in healthy young male and female volunteers.
    Learned-Coughlin, SM
    Putcha, L
    Ramanathan, R
    Venitz, J
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1998, 63 (02) : 230 - 230
  • [10] PK/PD correlation of endothelin a receptor inhibition and transient peak headache in healthy volunteers.
    Zhou, SY
    Donahue, S
    Moore, T
    Tay, LK
    Reeves, RA
    JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (09): : 1032 - 1032
12345